New Study: States Could Save Up to $1.8 Billion Annually by Prioritizing Lower-Cost Biosimilar Medicines

Pacific Research Institute analysis finds taxpayers and state employees could benefit from greater use of safe, effective alternatives to expensive biologic drugs SACRAMENTO, Calif., July 7, 2026 /PRNewswire/ -- At a time when states across the country are grappling with significant...